Pyrimidine antagonists and antifolates as antimalarial drugs

Advances in Experimental Medicine and Biology

Volumn 431, Issue , 1998, Pages 705-709

  Christopherson, Richard I ^a   Seymour, Kristen K ^a   Yea, Anthony E T ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; 6 THIODIHYDROOROTIC ACID; ANTIMALARIAL AGENT; ATOVAQUONE; CYCLOGUANIL; DAPSONE; FLUOROOROTIC ACID; FLUOROURACIL; FOLIC ACID ANTAGONIST; FOLINIC ACID; N [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] N' ISOPROPYLIMIDOCARBONIMIDIC DIAMIDE; OROTIC ACID; PIRAZOFURIN; PROGUANIL; PYRIMIDINE ANTAGONIST; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALARIA; PARASITE CONTROL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PYRIMIDINE SYNTHESIS;

PLASMODIUM FALCIPARUM;

EID: 0031832979     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5381-6_136     Document Type: Conference Paper

References (12)

1. Christopherson, R.I., Schmalzl, K.J., and Sharma, S.C. ,1987, Enzyme inhibitors. Complete patent specification: Australia 77692/87, Japan 220095/87, USA 091, 761, South Africa 7/6552, Europe 87307744.0.
2. Christopherson, R.I., Schmalzl, K.J., Szabados, E., Goodridge, R.G., Harsanyi, M.C., Sant, M.E., Algar, E.M., Anderson, J.E., Armstrong, A., Sharma, S.C., Bubb, W.A. and Lyons, S.D. ,1989, Mercaptan and dicarboxylate inhibitors of hamster dihydroorotase. Biochemistry, 28:463.
3. Crisp, L.B., Smith, S.M., Mathers, M.A.G., Young, G.A.R., Lyons, S.D. and Christopherson, R.I., 1996, Effects of cytosine arabinoside on human leukaemia cells. Int. J. Biochem. Cell Biol., 28: 1061.
4. Ferone, R., Burchall, J.J. and Hitchings, G.H., 1969, Plasmodium berghei dihydrofolate reductase. Isolation, properties and inhibition by antifolates. Mol. Pharmacol., 5: 49.
5. McCulloch, J.L. and Maren, T.H., 1974, Dihydropteroate synthase from Plasmodium berghei: isolation, properties and inhibition by dapsone and sulfadiazine. Mol. Pharmacol., 10: 140.
6. Queen, S.A., Vanderjagt, D.L. and Reyes, P., 1990, In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism. Antimicrob. Agents Chemo. 34: 1393.
7. Rieckmann, K.H., 1973, The in vitro activity of experimental antimalarial compounds against strains of Plasmodium falciparum with varying degrees of sensitivity to pyrimethamine and chloroquine. Chemotherapy of malaria and resistance to antimalarials. World Health Organisation Technical Report Series 529:58.
8. Scheibel, LW. and Sherman, I.W., 1988, In Malaria: Principles and Practiice of Malariology (Wernsdorfer, W.H. and McGregor, I. eds.). Vol 1, p 234. Churchill Livingstone. Melbourne.
9. Seymour, K.K., Lyons, S.D., Phillips, L., Rieckmann, K.H., and Christopherson, R.I., 1994, Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry, 33: 5268.
10. Szabados, E., Duggleby, R.G. and Christopherson, R.I., 1996, Metabolism of adenosine and deoxyadenosine by human erythrocytes and CCRF-CEM leukemia cells. Int. J. Biochem. Mol. Biol., 28: 1405.
11. Trager, W. and Jensen, J.B., 1976, Human malaria parasites in continuous culture. Science, 193: 673.
12. Yeo, A.E.T., Seymour, K.K., Rieckmann, K.H. and Christopherson, R.I., 1997, Effects of folic and folinic acid on the activities of cycloguanil and WR99210 against Plasmodium falciparum in in erythrocytic cultures.Ann. Int. Med. Parasitol., 91: 17.